$
19
million during the 12 weeks ended March 22, 2025 and March 23, 2024, respectively.
Our weighted-average Black-Scholes fair value assumptions are as follows:
Note 7 -
Pension and Retiree Medical Benefits
The components of net periodic benefit cost/(income) for pension and retiree medical plans are as follows:
We regularly evaluate opportunities to reduce risk and volatility associated with our pension and retiree medical plans.
In the 12 weeks ended March 22, 2025 and March 23, 2024, we made discretionary contributions of $
250
million and $
150
million, respectively, to our U.S. qualified defined benefit plans, and $
29
million and $
27
million, respectively, to our international defined benefit plans.
15
Table of Contents
Note 8 -
Debt Obligations
In the 12 weeks ended March 22, 2025, we issued the following notes:
(a)
Excludes debt issuance costs, discounts and premiums.
The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper.
In the 12 weeks ended
March 22, 2025
, $
1.5
billion of U.S. dollar-denominated senior notes matured and were paid.
As of March 22, 2025, we had $
4.8
billion of commercial paper outstanding, excluding discounts.
Note 9 -
Financial Instruments
We are exposed to market risks arising from adverse changes in:
•
commodity prices, affecting the cost of our raw materials and energy;
•
foreign exchange rates and currency restrictions; and
•
interest rates.
There have been no material changes during the 12 weeks ended March 22, 2025 with respect to our risk management policies or strategies and valuation techniques used in measuring the fair value of the financial assets or liabilities disclosed in Note 9 to our consolidated financial statements in our 2024 Form 10-K.
Certain of our agreements with our counterparties require us to post full collateral on derivative instruments in a net liability position if our credit rating is at A2 (Moody’s Investors Service, Inc.) or A (S&P Global Ratings) and we have been placed on credit watch for possible downgrade or if our credit rating falls below either of these levels. The fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of March 22, 2025 was $
143
million. We have posted
no
collateral under these contracts and
no
credit-risk-related contingent features were triggered as of March 22, 2025.
The notional amounts of our financial instruments used to hedge the above risks as of March 22, 2025 and December 28, 2024 are as follows:
(a)
In billions.
As of March 22, 2025, approximately
16
% of total debt was subject to variable rates, after the impact of the related interest rate swap contracts, compared to approximately
13
% as of December 28, 2024.
16
Table of Contents
Debt Securities
Held-to-Maturity
As of March 22, 2025, we had $
44
million of investments in foreign government treasury held-to-maturity debt securities